Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Gynecology · Primary Ovarian Insufficiency

Recognizing Symptoms and Securing a Diagnosis

At a Glance

Primary Ovarian Insufficiency (POI), often called premature menopause, is diagnosed in women under 40 who miss periods for four or more months. A definitive diagnosis requires two elevated FSH blood tests taken at least four weeks apart to confirm the condition.

When your periods become irregular or stop altogether before age 40, it can be a confusing and distressing experience. Getting a definitive diagnosis is the first step toward understanding what is happening in your body and protecting your long-term health. Primary Ovarian Insufficiency (POI) occurs when the ovaries stop functioning normally earlier than expected [1]. While it is sometimes called “premature menopause,” POI is different because ovarian function can occasionally fluctuate, meaning periods or even spontaneous pregnancy may still occur in some cases [2][3].

Common and Overlooked Symptoms

The most recognizable signs of POI are related to hypoestrogenism (low estrogen levels). While many people expect “classic” menopause symptoms, they can manifest differently in younger women.

  • Menstrual Changes: The primary sign is amenorrhea (no periods) or oligomenorrhea (infrequent periods) for at least four consecutive months [4].
  • Fluctuating Symptoms: It is common for symptoms to come and go unpredictably from month to month as your ovaries sputter, which can make the early stages feel incredibly confusing [4].
  • Vasomotor Symptoms: These include hot flashes (sudden feelings of heat) and night sweats [5].
  • Mood and Cognitive Changes: Many women report “brain fog,” difficulty concentrating, and increased psychological distress, including depression or anxiety [6][7].
  • Physical Changes: Low estrogen can cause vaginal dryness, painful intercourse, and sleep disturbances [4].
  • Silent Symptoms: Over time, POI can lead to osteopenia (decreased bone density) and an increased risk of cardiovascular disease, even if you do not “feel” these changes [5][8].

The Road to a Definitive Diagnosis

Diagnosis is not based on symptoms alone; it requires specific blood tests and a review of your menstrual history. For years, the gold standard has been the ESHRE guidelines (European Society of Human Reproduction and Embryology).

The Diagnostic Criteria

To be formally diagnosed with POI, your doctor should strictly adhere to the following ESHRE criteria [4]:

  1. Age: You must be under the age of 40.
  2. Menstrual History: You have experienced at least four months of irregular or absent periods.
  3. FSH Levels: Follicle-Stimulating Hormone (FSH) is a hormone that signals the ovaries to release an egg. In POI, the body produces more FSH to try to “jumpstart” the ovaries.
  4. Number of Tests: The ESHRE guidelines strictly require two elevated FSH tests (greater than 25 IU/L) taken at least four weeks apart. Because hormone levels can fluctuate wildly, a single test is never enough to confirm this life-altering diagnosis [9].

Essential Blood Tests

  • FSH: The primary marker used to confirm POI.
  • Estradiol: This measures the main form of estrogen; levels are typically low in POI [10].
  • AMH (Anti-Müllerian Hormone): This is a marker of your ovarian reserve (egg supply). In POI, AMH is typically very low or undetectable [11][12].

Avoiding Misdiagnosis

POI is frequently confused with other conditions that cause periods to stop. Distinguishing between them is vital for receiving the correct treatment.

  • PCOS (Polycystic Ovary Syndrome): While both cause irregular periods, PCOS typically involves high AMH and a high number of follicles, whereas POI involves low AMH and high FSH [9][13].
  • Functional Hypothalamic Amenorrhea (FHA): This occurs when the brain stops signaling the ovaries due to stress, excessive exercise, or low body weight. In FHA, FSH levels are usually low or “normal,” whereas in POI, they are high [14].

Next Steps After Confirmation

Once a diagnosis is made, your doctor should investigate the underlying cause. This often includes a karyotype (a test to look at your chromosomes) and a test for the FMR1 premutation (the most common genetic cause) [15][16]. Because POI is sometimes associated with other conditions, you may also be screened for autoimmune issues, such as Hashimoto’s thyroiditis [17][18].

Common questions in this guide

How is Primary Ovarian Insufficiency (POI) diagnosed?
POI is diagnosed if you are under the age of 40 and have had absent or irregular periods for at least four months. The diagnosis must be formally confirmed with two separate blood tests showing elevated FSH levels, taken at least four weeks apart.
What is the difference between POI and premature menopause?
While the terms are often used interchangeably, POI is slightly different from premature menopause because ovarian function can fluctuate unpredictably. This means a woman with POI might still occasionally have a period or even experience a spontaneous pregnancy.
What blood tests are needed to check for early menopause?
Your doctor will primarily check your Follicle-Stimulating Hormone (FSH), which is abnormally high in POI. They will also likely test your estradiol and Anti-Müllerian Hormone (AMH) levels, which are typically very low when you have this condition.
Can POI be misdiagnosed as PCOS?
Yes, because both conditions can cause absent or irregular periods. However, a PCOS diagnosis typically involves high AMH and many ovarian follicles, whereas POI involves low AMH and high FSH.
What genetic tests do I need after a POI diagnosis?
After confirming a POI diagnosis, doctors often recommend a karyotype test to look at your chromosomes. They may also order a specific test for the FMR1 gene premutation, which is a common genetic cause of the condition.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What were my specific FSH, estradiol, and AMH levels, and how do they compare to the ESHRE diagnostic criteria?
  2. 2.Have we completed the mandatory second FSH test four weeks from the first one to confirm this diagnosis?
  3. 3.How can you be sure my symptoms aren't caused by PCOS or functional hypothalamic amenorrhea?
  4. 4.Should we perform a karyotype or FMR1 gene test to look for a genetic cause for my ovarian insufficiency?
  5. 5.Do you recommend screening for autoimmune conditions, such as thyroid or adrenal issues, based on my diagnosis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Autoimmune Diseases in Patients with Premature Ovarian Insufficiency-Our Current State of Knowledge.

    Szeliga A, Calik-Ksepka A, Maciejewska-Jeske M, et al.

    International journal of molecular sciences 2021; (22(5)) doi:10.3390/ijms22052594.

    PMID: 33807517
  2. 2

    Successful Pregnancy in a Poor Responder: Natural In Vitro Fertilization, Menopause Treatment With Oral Contraceptives, and Anti-Müllerian Hormone as a Predictor.

    Voros C, Mavrogianni D, Stavros S, et al.

    Cureus 2024; (16(11)):e74650 doi:10.7759/cureus.74650.

    PMID: 39735088
  3. 3

    Spontaneous pregnancy in a patient with premature ovarian insufficiency - case report.

    Calik-Ksepka A, Grymowicz M, Bronkiewicz W, et al.

    Przeglad menopauzalny = Menopause review 2018; (17(3)):139-140 doi:10.5114/pm.2018.78560.

    PMID: 30357029
  4. 4

    Evidence-based guideline: premature ovarian insufficiency†‡.

    , Panay N, Anderson RA, et al.

    Climacteric : the journal of the International Menopause Society 2024; (27(6)):510-520 doi:10.1080/13697137.2024.2423213.

    PMID: 39647506
  5. 5

    Bone mineral density in patients with primary ovarian insufficiency: A systematic review and Meta-Analysis.

    Jiang M, Gao Y, Hou H, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2024; (295()):219-227 doi:10.1016/j.ejogrb.2024.02.013.

    PMID: 38387304
  6. 6

    Relationship between menopausal status and suicidal behavior among the Korean population.

    Son J, Lee W

    Maturitas 2025; (195()):108221 doi:10.1016/j.maturitas.2025.108221.

    PMID: 39985948
  7. 7

    The Relationship Between Menopausal Status and Depression in U.S. Women: Insights from the NHANES 2017-March 2020 Cross-Sectional Study.

    Pei J, Chen J, Liu L, Li M

    Actas espanolas de psiquiatria 2025; (53(6)):1223-1236 doi:10.62641/aep.v53i6.1998.

    PMID: 41437751
  8. 8

    Coronary artery calcification in middle-aged women with premature ovarian insufficiency.

    Gunning MN, Meun C, van Rijn BB, et al.

    Clinical endocrinology 2019; (91(2)):314-322 doi:10.1111/cen.14003.

    PMID: 31049984
  9. 9

    Premature ovarian insufficiency - aetiopathology, epidemiology, and diagnostic evaluation.

    Rudnicka E, Kruszewska J, Klicka K, et al.

    Przeglad menopauzalny = Menopause review 2018; (17(3)):105-108 doi:10.5114/pm.2018.78550.

    PMID: 30357004
  10. 10

    Primary Amenorrhea and Premature Ovarian Insufficiency.

    Yatsenko SA, Witchel SF, Gordon CM

    Endocrinology and metabolism clinics of North America 2024; (53(2)):293-305 doi:10.1016/j.ecl.2024.01.009.

    PMID: 38677871
  11. 11

    Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review.

    Nelson SM, Davis SR, Kalantaridou S, et al.

    Human reproduction update 2023; (29(3)):327-346 doi:10.1093/humupd/dmac045.

    PMID: 36651193
  12. 12

    Clinical Utilities of Anti-Müllerian Hormone.

    Russell N, Gilmore A, Roudebush WE

    Journal of clinical medicine 2022; (11(23)) doi:10.3390/jcm11237209.

    PMID: 36498783
  13. 13

    Gonadotropin Activity during Early Folliculogenesis and Implications for Polycystic Ovarian Syndrome and Premature Ovarian Insufficiency: A Narrative Review.

    Longobardi S, Klinger FG, Zheng W, et al.

    International journal of molecular sciences 2024; (25(14)) doi:10.3390/ijms25147520.

    PMID: 39062762
  14. 14

    Endocrine factors associated with infertility in women: an updated review.

    Concepción-Zavaleta MJ, Coronado-Arroyo JC, Quiroz-Aldave JE, et al.

    Expert review of endocrinology & metabolism 2023; (18(5)):399-417 doi:10.1080/17446651.2023.2256405.

    PMID: 37702309
  15. 15

    Position statement on the diagnosis and management of premature/primary ovarian insufficiency (except Turner Syndrome).

    Christin-Maitre S, Givony M, Albarel F, et al.

    Annales d'endocrinologie 2021; (82(6)):555-571 doi:10.1016/j.ando.2021.09.001.

    PMID: 34508691
  16. 16

    Premature ovarian insufficiency: clinical orientations for genetic testing and genetic counseling.

    Barros F, Carvalho F, Barros A, Dória S

    Porto biomedical journal 2020; (5(3)):e62 doi:10.1097/j.pbj.0000000000000062.

    PMID: 33299945
  17. 17

    Excess of severe autoimmune diseases in women with premature ovarian insufficiency: a population-based study.

    Savukoski SM, Silvén H, Pesonen P, et al.

    Human reproduction (Oxford, England) 2024; (39(11)):2601-2607 doi:10.1093/humrep/deae213.

    PMID: 39322013
  18. 18

    Immunophenotypic profiles and inflammatory markers in Premature Ovarian Insufficiency.

    Kunicki M, Rzewuska N, Gross-Kępińska K

    Journal of reproductive immunology 2024; (164()):104253 doi:10.1016/j.jri.2024.104253.

    PMID: 38776714

This page provides educational information about Primary Ovarian Insufficiency (POI) symptoms and diagnostic criteria. It is not a substitute for professional medical advice, so please consult your healthcare provider regarding your specific test results.

Get notified when new evidence is published on premature menopause.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.